Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05559333
Other study ID # KA-17057
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 12, 2017
Est. completion date March 24, 2022

Study information

Verified date September 2022
Source Hacettepe University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to compare the clinical performances of high-viscosity glass ionomer (GI), glass carbomer (GC), zirconia-reinforced GI (ZIR), and bulk-fill (BF) composite resin restorations.For this purpose, two calibrated operators placed 128 restorations in 30 patients with a mean age of 21 years. The restorations will be evaluated by one examiner at baseline and at 6, 12, 18,24, and 48 months using the modified US Public Health Service criteria. The data will statistically analyzed.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date March 24, 2022
Est. primary completion date February 15, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - patients presenting 1) at least four single-surface occlusal caries on their posterior molar teeth (first and/or second molars); 2) teeth to be restored had to be vital and without pulpal or periodontal disease, pain, and preoperative sensitivity; 3) teeth should be in occlusion; and 4) must agree to come to follow-up appointments. Exclusion Criteria: - patients with 1) poor oral hygiene, serious health problems, and/or heavy bruxism; 2) partly erupted teeth; 3) absence of adjacent and antagonist teeth; 4) teeth with interproximal caries; and 5) inability to attend recalls.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
class I restoration placement
zirconomer, glass carbomer, glass ionomer and composite resin class I restorations were placed.

Locations

Country Name City State
Turkey Hacettepe University Ankara Altindag

Sponsors (1)

Lead Sponsor Collaborator
Hacettepe University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Retention Alpha for at least 90% of the restorations The primary factor for determining the clinical performance of a restorative material is the retention rate. It represents the survival rates of the restorations after a period of time. According to ADA guidelines, a restorative material should show at leat 90% alpha retention rate after 18 months to be considered as clinically acceptable. The retention is assesed as alpha (retentive restoratation) or charlie (failed restoration). Clinical evaluation is performed to examine if the restoration is in place or has fallen. 24 months
Secondary marginal adaptation score alpha It represents the marginal integrity of the restorations. It is scored as alpha (perfect marginal adaptation), bravo (detectable marginal discrepency, clinically acceptable) or charlie (marginal crevice, clinically unacceptable). The examination of marginal adaptation is performed by clinical examination of the restoration with probe. 24 months
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06107218 - Performance Of Class I Composite Restorations After Cavity Finishing By Air Abrasion Versus Diamond Stone N/A
Not yet recruiting NCT04738604 - Clinical Performance and Wear Resistance of Two Nano Ceramic Resin Composite in Class I Cavities N/A
Active, not recruiting NCT03184025 - Effect of Surface Sealant Application on Clinical Performance Occlusal Restorations N/A